Guillain-Barr Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
Condition: Guillain-Barre Syndrome Interventions: Device: immunosorbent column; Drug: intravenous immunoglobulin Sponsor: The First Affiliated Hospital of Zhengzhou University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2021 Category: Research Source Type: clinical trials